A genetic test to inform decisions about what antiplatelet to use following percutaneous coronary intervention (PCI) significantly reduced the number of major cardiovascular or cerebrovascular events in a single-center study published in Circulation: Genomic and Precision Medicine.

Chicago-based Outcome Health announced a collaboration with advocacy group WomenHeart: The National Coalition for Women with Heart Disease, to “provide actionable educational information” to cardiology providers across Outcome Health’s network of providers.

Abiomed announced April 2 its Impella CP heart pump has received expanded FDA premarket approval for its SmartAssist technology. SmartAssist utilizes an optical sensor to inform exact positioning for the device and provide data on left ventricular pressure, end-diastolic pressure and cardiac power output.

Heart failure was not associated with an increased risk of cancer in a study of almost 30,000 men despite previous reports linking the two conditions.

Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.

An international group of scientists identified 22 new genetic risk factors for stroke, more than tripling the number of gene regions known to impact stroke risk. The total number of stroke risk loci is now 32, the researchers reported March 12 in Nature Genetics.

Women whose babies are born with congenital heart defects may have a higher risk of cardiovascular disease themselves, according to a study of more than one million women published online April 2 in Circulation.

A 6-month-old German Shepherd was the beneficiary of a successful cardiac ablation at Cornell University Hospital for Animals, one of only two centers in the U.S. that regularly offers the procedure for dogs.